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                     INTRODUCTION  
            Coronary artery Ectasia (CAE) has been defined as an abnormal 
dilatation of coronary artery, with luminal diameter exceeding 1.5 times the 
adjacent  normal reference segment. According to the extent of involvement 
ectasia may be labelled as focal or diffuse. Prevalence of CAE varies from 0.3% 
to 6 % .The highest prevalence reported from India and Pakistan (10-12%
 
&12.5%  respectively).  
            CAE may occur as an isolated form but most commonly seen in 
association with obstructive CAD . Ectasia is often viewed as a variant form of 
obstructive  Coronary Artery Disease (CAD) and atherosclerosis is considered as 
a contributing factor in more than half of the cases. Although the association 
with atherosclerotic CAD is well evident, the relationship between traditional 
atherosclerotic risk factors and Ectasia remains controversial. Especially its poor 
correlation with Diabetes mellitus suggested Ectasia is a distinctive form of 
atherosclerosis characterized by positive remodeling–(Glagovian phenomenon) 
in contrast to obstructive disease (Negative Remodeling) .Hemodynamic factors 
like flow, stretch, shear stress along with inflammatory signals were proposed as 
the  triggers for this abnormal vascular remodeling and postulated as the link 
between atherosclerosis and CAE in susceptible individual. Multiple studies in 
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this area were showing conflicting evidence, hence the exact pathogenitic  
mechanism still not conclusively defined and  in hypothetical stage .  
               Thrombus formation, vasospasm ,slow flow, dissection  were 
proposed as the pathophysiological mechanisms of clinical events related with 
CAE . Clinically the  most common manifestation of CAE is  angina, unstable 
angina myocardial infarction also occur in 30% of individuals, very rarely 
caused  sudden cardiac death .Long term prognosis remains unclear. Even 
isolated ectasia is not a benign entity can present with myocardial infarction 
during follow up .No consensus or guidelines available for the management of 
Coronary Artery Ectasia.. In acute settings heparin infusion , if necessary 
thrombolysis considered mandatory . Medical management with Antiplatelet 
dugs is universally accepted ,but role of anticoagulation remain controversial in 
long term . In view of prothrombotic milieu , complexities related with 
Percutaneous Intervention Coronary Artery in ectatic segment  Bye pass 
Grafting(CABG)  is the preferred revascularization  approach.  
           The etiopathogenisis of this entity puzzled the clinician since its 
discovery, but still there are some unclear undefined areas  clinical significance 
remains uncertain  and  there is no consensus opinion regarding management. 
Hence further research is essential to solve these enigmas. Being in the country 
with   highest prevalence of CAE, we planned this study to analyze the risk 
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factors, clinical presentation and angiographic characteristics of patients with 
Coronary Artery Ectasia , also to assess the prognosis during the index 
hospitalization  as well as  during follow up 
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            REVIEW  OF  LITERATURE 
 
        Coronary arteries are the first branch of aorta to supply the need of 
the heart itself. Right and left coronary arteries arises from the root of aorta with 
their   ostium .Both coronaries completely encircling the heart like a crown   
This crown like or wreath like arrangemnent (stephanos – Greek) formed the 
basis of nomenclature of coronary artery .Coronary   means crown  this  is 
derived from the coronarius a Latin word .But  Coroanrious is a translated form 
of Greek word stephanos (wreath), means wreath-like or  crown-like 
arrangement  . 
 
History  and Nomenclature  of  Ectasia  
 
    Coronary artery dilatation is a well-known but less common  entity 
diagnosed during coronary angiography . Older studies used the term Coronary 
Artery Aneurysm to label these dilated coronaries. The  Coronary artery 
aneurysm was first described by Giovanni-Battista Morgagni 1761
1
.The first 
clinical case report  describing right coronary artery aneurysm was given by 
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Bourgon in 1812
2
  which is a post mortem report of  a patient experienced 
sudden  cardiac death .The first ante mortem (angiographic ) demonstration was 
done by T Munkner  (1958)
3
  in his report of a boy with Coronary AV fistula   
The term “Ectasia” was coined by Lars Bjork in his report of 3 patients with 
Tetralogy of Fallot 
4
. Syed ,and Lesch discriminated Coronary Ectasia(CAE) as 
diffuse dilatation of coronary artery involving more than 50% of the vessel, on 
the other hand focal dilatation as  Coronary Artery Aneurysm (CAA)
5
 .Until 
1967 only postmortem studies were available Of which excellent compilation of 
89 case was done by Daoud  et al in 1963
6
 . In 1976 Markis et al
7
 published his 
study on ectasia and  proposed a classification based on anatomical extent . He 
also defined ectasia as localized and diffuse . In 1983  Swaye and 
coworkers,reviewed the 20,087 patients  from Coronary Artery Surgery Study 
registry(CASS registry) reported an incidence of 4.9%. 8  
 
Epidemiology :    
         
                 The prevalence of Coronary Artery  Ectasia  varies form 0.3
9
-
12.5%
10
 among patients undergoing diagnostic angiography for varies ischemic 
syndromes. Highest prevalence reported from India  10% -12% 
11
and Pakistan 
12.5%. 
6 
 
 
 
Table 1 Comparative incidence of ectasia at coronary angiography 
         Study                             Total No of cases   Cases of ectasia    % ectasia 
Coronary Artery Surgery Study         20087                     978                      4.9% 
Harikrishnan et al 2000  India            3200                        144                      4.5% 
Lam  Kt Ho     2008  Singapore         8641                         104                     1.2% 
Pinar Bermúdez E, et al.  Spain            4332                        147                   3.39% 
Riffat Sultana  et al2008 Pakistan                                       140                     2.8% 
 
Etiology 
 
             Coronary Artery  Ectasia can be due to congenital or acquired 
etiology. Congenital CAE accounts for only20-30% of cases and  the 
remaining were acquired . Congenital CAE usually associated with other 
Congenital Heart Disease like  ventricular septal defects , pulmonary stenosis , 
Bicuspid Aortic valve Aortic root dilatation , and cyanotic diseases. 
7 
 
Atherosclerosis is  the major acquired cause for CAE and it is responsible for  
50-60% of cases . CAE is associated with obstructive CAD in more than three 
fourth  of the patients indicating atherosclerotic etiology. Other causes include 
inflammatory diseases and connective tissue disorders(10-20%) like  SLE , 
Scleroderma ,Poly Arteritis Nodosa , Takayasu arteritis ,Ehlers -Danlos 
Syndrome .Kawasaki disease an acute vasculitis commonly affects children 
requires special mention . According to Cohen & O’ Gara, 2008, Kawasaki 
disease is the most common etiology in the Far East
12
. Other rare etiologies 
which mainly causes focal ectasia include infection ,drugs, iatrogenic trauma 
during percutaneous interventions. It is difficult to discriminate congenital 
from acquired based on clinical and angiographic criteria 
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Table 2: Etiologies for Coronary Ectasia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.Congenital  
2.Atherosclerosis 
3.Inflammatory  
            Vasculitis :  Kawashaki ,PAN,  
                                 Takayasu  Bechets ,Syphilis ,SLE  
             Connective Tissue disorders:   
                    Rheumatoid arthritis , Scleroderma                                          
                   Ankylosing Spondylitis,   
4.Heriditory Collagen Defects : 
                  Marfan Syndrome ,Ehlers Dalos Syndrome   
 
5.Drugs   :  Cocaine, Amphetamine  
6.Infectious :  Syphilis ,Mycobacterial ,Fungal  
7.Iatrogenic : Following Percuteneous Coronary Intervention 
 
9 
 
Pathogenisis of CAE  
    
                Coexistence CAE with obstructive CAD in approximately 80% of 
cases , same  risk factor profile along with  histological features suggested 
similar pathogenitic mechanism and atherosclerosis as the common denominator 
. Hence CAE was considered as variant expression of atherosclerosis. Although 
CAE has strong association with atherosclerosis and its risk factors, unique but 
consistent observation is low incidence (inverse or negative association) of 
Diabetes Mellitus and lower age in CAE population compare to CAD group 
13,14
 
Following theories were proposed to explain the pathogenesis of Ectasia 
1. Hemodynamic  
2. Inflammatory hypothesis  
3. Vascular Remodeling theory  
4. Genetic theory  
5. Generalized vascular disorder  
6. Excessive vasodilator mechanism (NO mediated) 
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        Knowledge about the histopathological difference between obstructive 
CAD and CAE will help in better understanding of these pathogenitic 
mechanisms.  
             CAE is form of positive remodeling of arterial wall  in contrast to CAD 
which is a form of  negative remodeling .Histopathologically  atherosclerotic 
CAD is mainly a disease of intimal layer characterized by intimal proliferation 
with spilling of plague material into tunica media, but medial layer and elastic 
lamina remain intact. On the contrary   histopathological examination of arterial 
wall  in CAE patients  typically reveal marked destruction and reduction of the 
elastic fibers  in the tunica media with disruption of both internal and external 
elastic lamina
1516
. Such a extensive medial destruction out of proportion to the 
intimal involvement have been reported with non-atherosclerotic CAE also
17,
 
18
. 
Hence significant loss of musculoelastic component in the tunica media layer of 
coronary arteries is the crux  in the  pathogenesis Coronary Ectasia
19
.    
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Table : 2 Difference between Coronary artery Ectasia and CAD  
 
 
“Coutesy : Ref 20” 
 
 
Hemodynamic theory :  
            Dauod et al. postulated that aneurysms (focal ectasia) are formed from  
transformation of kinetic energy to potential energy and pressure abnormalities 
beyond the level of stenosis.  Siouffi et al. suggested that the excessive velocity 
12 
 
of blood flow, with resultant  in increased shear stress at the level of stenosis 
induce endothelial injury and  poststenotic vasodilation . Recently  Chatzizisis et 
al.. in their experimental study proved the pivotal role of low Endothelial Shear 
Stress (ESS ) as a trigger for the transformation of early atherosclerotic plaque to 
expansive remodeling ( Positive remodeling Ectasia)
21
 this has been confirmed 
in a in vivo study
22
  
 
Vascular Remodeling Theory :  
 
    Coronary Ectasia has been viewed as form of excessive positive 
remodeling(expansive remodeling ) of arterial wall to accommodate the  
increasing plaque burden during initial stages of plaque and after an episode of 
plaque rupture
23
 This expansion may itself induce low shear stress inturn self-
perpetuate a vicious cycle 
 
Inflammatory Hypothesis :  
 
             Atherosclerosis is considered to be a chronic inflammatory disease . 
Spilling over of inflammatory cells from intimal into the tunica media layer and 
resultant destruction leads to ectasia formation. Along with hemodynamic 
13 
 
factors inflammation is considered as the prime pathogenic  link between 
atherosclerosis and CAE. Cytokine induced extensive inflammation involving 
all the 3 layers of arterial wall is the underlying mechanism for CAE . 
Tokgozoglu et al., demonstrated that  patients with CAE have elevated levels 
inflammatory markers like plasma interleukin-6(IL6) and C-reactive protein 
(CRP)  compared with those with normal coronaries
24
.In addition, cell adhesion 
molecules(VCAM ,ICAM ) which help in transmigration of inflammatory cells 
also increased in sera of patients with ectasia. To support the inflammatory 
hypothesis Neutrophil Lymphocyte Ratio (NLR ) a maker of inflammation is 
significantly higher  in patient with isolated Ectasia compared to people with 
normal coronaries which indicate the role of neutrophil .  
 
 Extracellular matrix destruction  and loss of Tunica media : 
 
            The Neutrophils secrete elastase Matrix MetalloProteinase (MMP3) 
MMP2 along with collagenase. In addition secretion of Tissue Inhibitor of 
Mellaoproteinase(TIMP) from macrophages and smooth muscle cell were 
reduced by IL6.TIMP  is a regulator of MMP activity in its absence there will be  
excessive ECM destruction by MMP in turn leads to CAE . Lamblin et al. 
observed more frequent  expression MMP 3 5A/5A genotype in patients with 
14 
 
CAE than in  CAD patients
25
.  Senzaki H, demonstrated  that high circulating 
levels of MMP-3  in Kawasaki disease with coronary involvement  explains the 
role of MMP in Ectasia formation
26
   , 
 
 
Vasodilatation (NO mediated ) theory : 
 
        Sorrell
27
 postulated that  NO mediated excessive vasodilatation  is the most 
common mechanism specifically in patients with non atherosclerotic CAE  
Enhanced NO production via iNOS pathway   primarily mediated by  
inflammatory cells resulting in high NO levels and other toxins, which disrupt 
the extracellular matrix  leads to thinning of arterial wall and  Ectasia
28
 Higher 
incidence of Ectasia has been observed in population exposed to a herbicide 
spray which contains acetylcholine esterase inhibitor .This agent increase acetyl 
choline mediated NO production
29
  Moreover the role of NO in inflammation 
and aneurysm formation has been experimentally proved 
30
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Generalized vascular disorder : 
  
             CAE may be a part of generalized disorder (deficiency) arterial wall as 
evidenced by its association with  aneurysm of ascending aorta
31
 ,abdominal 
aorta
32
  Similarly coexistence of CAE with Venous disorders like varicosities of 
coronary veins  and leg veins and pampiniform plexus also demonstrated . 
Genetic linkage with Ectasia have been suggested specifically with  MMP-3 
gene (MMP-3 5A allele) disruption
33
,  polymorphism of angiotensin-converting 
enzyme.   HLA linkage demonstrated  with HLA-DR B1* 13, DR16, DQ2, and 
DQ5, genes
34
 
 
                    In a genetically susceptible individual with systemic risk factors  
,self perpetuating vicious cycle among the hemodynamic factors, inflammation, 
ECM destroying enzymes (MMP) ,and expansive remodeling may transform the 
early atherosclerotic lesion in coronary artery to   Coronary Artery Ectasia  
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Figure  1: pathophysiology of Coronary Ectasia  
 
 
 
                  
 
 
         .       
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    Manginas et al hypothesized that pathogenesis of   coronary Ectasia can be 
explained by 2 different pathways  
Figure 2:  
Pathway 1:  CAE in patient with CAD             Pathway 2 : Isolated Ectasia  
 
 
Caridiovascular Risk factors and CAE : 
                    Traditional risk factors  have been studied in major studies .Except 
male sex ,age and Diabetes mellitus others did not provide any consistent results 
. Male dominance was noted in several studies 
35
 with ratio ranging from 1.7-
3:1
36
. Prevalence of CAE is relatively more common in younger population than 
CAD. Giannoglou GD, et al and other previous studies also reported similar 
observation indicated younger age among CAE patients
37
. Diabetes mellitus 
18 
 
warrants special note it consistently showed lower incidence ( negative 
association) among patients with CAE. 
Inverse Association of diabetes mellitus with CAE  ??  
   1. Atherosclerotic  coronary arteries undergo expansive remodeling(positive 
remodeling)  to accommodate an increasing plaque burden, especially during 
early stages of plaque accumulation
38
 
     2. Inflammation and the resultant overexpression of Matrix Metalloproteinase 
(MMP-3 activity) have been shown to play a significant role in the formation of 
aneurysmal disease like AAA and  coronary ectasia
39
. Lamblin et al. found that 
MMP-3 5A/5A genotype was significantly more frequent inpatients with CAE 
than in the control group of CAD patients 
 
     3. But the advanced glycation crosslinks in Diabetes Mellitus inhibit the 
matrix metalloproteinase activation and these enzymes are down regulated
40
 
 
    4. Diabetes Mellitus  promotes negative arterial wall remodeling(obstructive 
CAD )  or at least impairs compensatory arterial enlargement during the course 
of the atherosclerotic process
41
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    5.Advanced glycation end products formation on the connective tissue and 
matrix protein components result in significantly increased arterial stiffness in 
diabetic patients. 
            Smoking a common risk factor for CAD also found significantly 
associated with CAE. This has been attributed to the confounding effect of male 
dominance  among CAE population. Hypertension Dyslipidemia
42
 also 
implicated in the pathogenesis but contradictory results have been reported 
43
 . 
Similary  high BMI obesity also shown to be associated with CAE . Obesity was 
reported to increase  serum elastase activity
44
. Increased serum elastase can lead 
to destruction of ECM in tunica media of coronary arteries and result in 
ectasia(EVA study)
45
. Recently an Iranian study which specifically assessed the 
role of traditional risk factors  found no apparent correlation between CAE and 
conventional risk factors
46
 .Hence with available evidence the role of traditional 
risk factors remains controversial . 
 
Novel Risk factors and Ectasia : 
                   CAE patients have  histological similarity with  atherosclerosis, but 
only few patients with atherosclerosis develop ectasia .On the other hand nearly 
30-40%  cases CAE have non obstructive coronaries even in population who 
does not have other explanation like systemic inflammatory or connective tissue 
20 
 
diseases. To bridge the link , in addition to atherosclerosis excessive 
inflammatory activity has been convicted . 
        Along with atherosclerosis  role of inflammation was evaluated in many 
studies . Markers of inflammation from Neutrophil count, genetic level markers 
like polymorphism of MMP have been studied in patients with coronary ectasia 
and compared with obstructive CAD and normal coronaries. High neutrophil 
count low lymphocyte count with high Neutrophil : Lymphocyte ratio (NLR) 
have been noted in patients with patients with isolated Ectasia compared to 
normal population  which indicate the role of inflammation
47
. Hs CRP a well-
established marker of inflammation  also observed to be elevated in patients with 
CAE compared patients with obstructive CAD
48
. Even though some studies 
report contradictory results it was attributed to the study population
49
. Similarly 
soluble adhesion molecules like VCAM, ICAM, E selectin  which are involved 
in the essential steps of inflammation also found to be increased to suggest the 
role of inflammation . Mean platelet volume a marker of platelet activation 
incriminated as independent effector on the pathophysiology of atherosclerosis 
also been assessed and proved to be elevated in the Ectatic population compared 
to normal control population
50
 .  
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       Proteolytic imbalance characterized by hyperactivity of MMP , elastase 
with reduced level inhibitors of proteolysis (TIMP) have been demonstrated in 
patients with arterial, venodilation  like aneurysm, varicose veins ,and Ectasia 
29
 
. Red cell Distribution  Width (RDW) a marker of  variability of size of 
circulating  RBC have been viewed as strong predictor of cardiovascular risk 
and shown to be a marker of adverse outcome in acute cardiovascular disease 
also have been evaluated and found to have higher among patients with isolated 
Ectasia compared to healthy controls and it was positively correlated with CRP 
level .Exact independent pathogenic role of  high RDW in coronary ectasia was 
not known. It has been hypothesized that in patients with Ectasia RDW may be 
marker underlying active inflammation, oxidative stress  induced  damage to  
RBC. Inflammatory cytokines  can interfere with maturity of  RBC and it also 
prematurely release juvenile RBC into the circulation by its effect on 
erythropoietin
51
 . 
        Mean platelet volume a  marker of activated platelets indicating high 
metabolic and enzymatic activity of platelets with overexpression of 
glycoprotein Ib IIIa and  increased levels of thromboxane , alpha granules with 
its mediators involved in the process of platelet adhesion aggregation along with 
enhanced responsiveness to proaggregatory ADP than  prostacyclins . Studies 
have documented higher MPV in patients with ACS
52
 . 
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 Table3: Coronary artery Ectasia :Difference between etiologies   
 
 
 
As a conclusion we concur with the conclusion from  E Yetkin &      
J.Waltenberger after their excellent review on novel insights into 
23 
 
pathophysiology of coronary  ectasia  “with currently  available knowledge and 
evidence it is premature and not justified to conclude CAE as a variant of 
atherosclerosis . Considering the  slow progression and varying manifestations 
of atherosclerosis , CAE may be a stage (probably an early stage ) of  obstructive 
CAD. But still the time of transition or the factors responsible the transition 
uncertain needs to be unrevealed  . Or else the atherosclerotic process may itself 
triggered  at the sites of CAE” 
      
Patho physiology of myocardial ischemia : 
 
                   Hemodynamic alteration inside the inappropriately dilated coronary 
artery is not surprising and it is characterized by disturbances in filling and 
washout . Characteristic flow pattern include  
               1.Slow flow, 
               2.Stagnant flow, 
               3.Turbulent flow  
                      
   Angiogrphic signs of these flow alteration are  
              1.Delayed ante grade dye filling , 
              2.Stasis of the dye   
              3.Segmental backflow (milking phenomenon ).       
24 
 
              Delayed coronary flow has been demonstrated in isolated coronary 
aneurysms and it was attributed due to elevated resistance and reduction in 
Coronary Flow Reserve (CFR)
53
.. Kruger et al hypothesized these altered flow 
can induce myocardial ischemia demonstrated exercise induce myocardial 
ischemia
54
  Hamaoka, et al 
55
evaluated  coronary flow dynamics, CFR in 
Kawasaki disease patients found a reduced coronary flow velocity. The 
thrombolysis in myocardial infarction (TIMI) frame count(TFC ) is an 
angiographic  measure of coronary blood flow  was found to correlate well with 
Flo-wire derived velocity. Multiple studies demonstrated high TIMI frame count 
indicating slow flow
56
 in patients with CAE similarly finding was observed with 
magnetic resonance(MRI)  flow velocity (PFV) also
57
 . Gulec et al found lower 
myocardial  blush grade despite preserved epicardial flow which indicates   
disrupted  microcirculation
58
 . In a   land mark study  Akyurek et al
59
  measured 
coronary flow velocity dynamics and CFR (with Flowire-Doppler wire)  in 
patients with dilated coronaropathy  (isolated ectasia) and compared with 
healthy control .He demonstrated reduced resting flow velocity and low CFR 
following maximum hyperemic stimuli with intracoronary papaverine 
administration (1.51Vs2.67 ) .This suggested flow disturbances in the major 
epicardial vessel as well as microvascular dysfunction. High TFC also observed 
in non ectatic vessel of the same patient with ectasia .These observations proved 
25 
 
the notion of   Williams and Stewart  that “Ectasia as diffuse coronary arterial 
disease”60.Slow flow in CAE was also attributed to  non-inflammatory 
endothelial dysfunction and its relation  with erectile dysfunction  suggested two 
different mechanism of endothelial dysfunction. Influence of coexisting stenosis 
on  the TFC of patient with CAE also evaluated recently, Contrary to the 
expectation  authors found that TFC  has not been further impaired by the  
coexisting stenosis
61
 . 
        Myocardial infarction is attributed to thrombus formation inside the dilated 
segment and distal embolization.  Below a certain level of critical velocity 
viscosity of blood increases . Increased viscosity along with sluggish and 
turbulent flow results in loss of axial stream. Hence platelet and coagulation 
mechanisms are activated ,erythrocytes aggregability increases and thrombus 
formation occurs  . This has been already  demonstrated in Infarction related 
Ectatic vessel, which had low TFC, low TIMI flow  higher thrombus burden 
score , distal embolization with poor ST resolution, inadequate collateralization
62
 
.In addition to embolization spasm could also be mechanism infarction in Ectatic 
patients but the occurance of spasm is controversial reported to occur frequently 
in the border of ectasia
63
 . 
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Clinical Presentation : 
 
  
                          Coronary artery Ectasia commonly identified inpatients 
submitted for ischemic symptoms like angina ,it may be an incidental finding 
too .Unstable angina , ST Elevation and Non ST elevation myocardial infarction 
can also  occur. In their collective Kruger, et al reported 39% incidence Q and 
Non QMI .Acute left ventricular failure, pulmonary edema, ventricular 
arrhythmia are other manifestations  sudden cardiac death following rupture of 
aneurysm also reported. Rupture of ectasia into right sided chambers and 
coronary sinus have been reported with continuous murmur as an evidence of 
left to right shunt
64
. Demopoulos V et al reported previous history of MI in 
38.7% patients with dilated coronaropathy. 
 
Angiogrphic pattern & Classification  
                 Coronary artery dilatation maybe defined as Aneurysm or Ectasia  . In 
older days overlapping  use of both the terminologies ,coronary artery aneurysm 
, coronary artery ectasia led to under or over estimation of frequencies. 
Angiographically Falsetti and Carroll , Befeler et al  defined “Coronary artery 
Ectasia CAE  as non-obstructive lesions of coronary arteries with a luminal 
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dilation exceeding the 1.5- to 2.0-fold of normal diameters, and a coronary 
aneurysm (CAA) was defined as a dilation .2.0-fold of normal diameters. If no 
adjacent normal segment could be identified, the mean diameters of the coronary 
segments in a control group without heart disease served as normal values.” 
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Fig 3  Saccular & Fusiform ectasia  
 
    
Fig 4 Saacular (discrete or focal ectasia ) Ectasia  
          
          A                                                                 B  
Fig  5  :Coronary CT angigram (A)  corresponding Conventional Angiogram (B) 
thrombus can be seen as attenuation of contrast (*)  but in conventional angio it 
was seen as complete occlusion.  
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       Saccular Ectasia previously called as coronary aneurysm, is defined  as a 
coronary artery dilatation with  transverse diameter more than the longitudinal 
diameter . On the other hand  fusiform ectasia is aneurysmal  dilatation  with 
longitudinal diameter exceeding the transverse diameter .Coronary Ectasia is 
labelled as diffuse if it involves the entire length of  one particular segment of 
coronary artery without any normal dimension in between . Focal Ectasia or 
discrete ectasia is the one which involves only only a part of particular coronary 
arterial segment . 
Table 4: Classification of Coronary artery dilatation  
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        Initially Markis classified coronary artery Ectasia into 4 types in 
descending order of severity  based on their analysis 30 patients with coronary 
ectasia from a  group of 2457 patients.     
 
Table 5 : Markis classification               
 
 
       Harikrishnan et al 
65
 found difficulty in classifying all the types under 
Markis and they proposed  modified classification in  which 4 major type of 
Markis has been sub classified into 2 or 3 subtypes. Their classification  based 
on their analysis 144 cases of ectasia among 3200 Indian population with 
incidence of 4.5%. . 
 
Type Diffuse  Localised  
I Diffuse ectasia of 2 or all 3 
vessel 
 
II Diffuse in one vessl Localised in other 
III Diffuse in one vessel only  
IV  Localized or 
segmental Ectasia 
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Table : 6 Harikrishnan et al  classification 
 
 
 
 
Type I II III IV 
Sub 
types 
Diffuse Ectasia in 
2 or 3 vessels 
Diffuse Ectasia in 
one and 
Diffuse 
Ectasia in 
single vessel  
alone 
Localized 
Ectasia of 
a 
I a - Diffuse in 3   
           vessels 
Localized in one 
 
IV a- One vessel 
b 
Ib - Diffuse in 2  
       vessels and 
localized in one 
Localized in 2 
vessel 
IV  b- 2 vessels 
 
c 
Ic - Diffuse in  
two vessels 
 IV c – 3 vessels 
 
 
 
 
     
 
     
              In 2003 , Nyamu et al
66
 proposed another classification to segregate 
Left Main Coronary Artery (LMCA) Ectasia into separate category .They 
proposed the  classification based on their exclusive study on isolated ectaisa 
divided groups into 4 major types  2 or 3 subtypes in each major groups . 
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Table   Nyamu et al classification  
 
 
Type I II III IV 
Sub 
types  
Isolated Diffuse 
Ectasia in 2 or 3 
vessels 
Diffuse Ectasia  and 
discrete Ectasia in 
combination  
Isolated 
discrete ectasia  
Lefy Main 
Coronary 
involvement  
a 
I a - only one 
vessel  
IIa - Diffuse in ≥ 2 plus 
discrete in one  
IIIa -In one 
vessel  
IV a- Isolated 
LMCA 
involvement  
b 
Ib - Diffuse in 2  
or all 3 vessels 
IIb - Diffuse in one  
  vessel plus discrete≥ 2  
III b  ≥ 2 
coronaries  
  IV  b- LMCA 
plus other vessel  
        
c ----- 
III c Diffuse in one 
plus discrete in one  
  
 
 
 
               Majority of patients with ectasia have coexisting obstructive CAD  
ranged from 75-80%
8
. Iresepctive of its association with CAD Right Coronary 
Artery (RCA)the most common vessel to have coronary ectasia (45-75%)
8 
 
followed by Left Anterior Descending(LAD ) and Left Circumflex(LCX), 
LMCA is the least common vessel to be affected by ectasia 
65
 . But in cases of 
stenotic CAD , involvement LAD  RCA and LCX in descending order of 
frequency . The severity of  CAD assessed by incidence of single ,double or 
triple vessel disease remains same and not influenced by its association with 
CAE. Diffuse ectasia is less frequent with concomitant stenotic(obstructive) 
CAD but  more frequent among the dilated coronaropathy (isolated ectasia)  
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group,  often bilateral  and associated with aneurysm in other regions . Focal or 
discrete ectasia is more common with concomitant CAD group. Involvement of 
single vessel 60%-70%
35
 was reported to be more common in three vessel 
involvement is less common .But in a Chinese study equal proportion of 
single(31%) double(38%) triple (31%)vessel ectasia were reported. Prevalence 
of CAE in right coronary artery strongly associated with CAD in LAD. In two 
third of patients Ectasia  seen in the vessel without stenosis .In 1/3 of patients 
stenosis and ectasia coexist in thya same vessel . Of the various classification 
Markis Type 4 (Isolated focal ectasia ) & Harikrishnan Type 4 a ( Focal Ectasia 
of single vessel) is the commonest in a Turkish study. In a recent Chinese study 
also reported the same but specifically among patients with dilated 
coronaropathy Type III is the commonest one . An Indian study reported Type 
III ectasia as the commonest . In study by Harikrishnan et al found Type II as the 
commonest type. Higher predilection for ectasia in RCA is poorly understood . 
No uniformity in angiographic pattern also have not been explained clearly. 
 
 
Diagnostic Imagings :  
   
             Until the demonstration by Munkner et al in 1958  coronary ectasia was 
only a postmortem diagnosis . Since then angiography remains the gold standard 
for diagnosing and assessing the physiological characteristics of ectatic 
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vessel.But it can not differentiate true from false aneurysm and  emptied plaque 
cavities after plaque rupture is misdiagnosed as CAE by angiography 
.Intravascular Ultra sound IVUS ( is newer modality correctly assess the luminal 
size and characterize arterial wall changes  clearly differentiates the true 
aneurysm from the false one. In an IVUS based study authors demonstrated 
atheromatous changes inside the aneurysmal segment also and they highlighted 
the angiographic underestimation of stenosis severity at the ectatic segment 
67
. 
Even though characterizes the lumen and vessel wall ,the limitation of IVUS is 
still it is an invasive procedure requiring radiation. Recently  Coronary Artery 
Computed Tomography (CACT)and Coronary magnetic Resonance 
Angiography (Coronary MRA) are emerging as new tool .But still CACT 
limited by ionizing radiation but MRI doesn’t having the hazard of radiation. 
CACT based study documented the prevalence of CAE about 3-8%
68
.The 
hemodynamic assessment using contrast attenuation shown to have good 
correlation with conventional angiographic flow alterations
69
.Coronary MRA 
along with flow data (PFV) with its advantage of non invasive technique without 
the hazard of radiation may be a valuable tool for demonstrating thrombus and 
for follow up 
70,71 .
Echocardiography may be an initial noninvasive tool to 
recognize large aneurysm or  ectasia .but its sensitivity is very poor for coronary 
imaging in adults .But Trans Esophageal Echocardiography is a better tool than 
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TTE to visualize coronaries .and coronary flow reserve also can be measured but 
with inter, intra observer variation is high 
 
 
MANAGEMENT  :   
      The cuurently available options for therapeutic armamentarium for coronary 
ectasia include  
1. Medical management a) anticoagulation ,b)antiplatelet , c) vasodilators      
       (calcium channel blockers)  
2. Percutaneous intervention  
3. Coronary Artery Byepass Grafting 
4. Aneurysmorrhectomy  , aneurysm excision, distal ligation   
             But   no consensus or guidelines available for the  management of CAE. 
In the acute coronary syndrome(MI ,UA)  thrombolytic therapy and heparin 
infusion is justified because of the  thrombus load . On long term because of 
flow alteration with propensity for thrombus formation and embolization 
anticoagulation has been proposed by many authors but no randomized 
prospective trials available. The same scenario exist for antiplatelet therapy as 
well .But the following explanations justify the use of antiplatelet therapy .  
      1.Majority of CAE associated with CAD  
      2.Histopathological similarity between CAE and CAD  
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      3.Even in ectatic segment atheromatous lesion evident by IVUS 
     4. Approximately .30% patients with ectasia had prior history MI  
     5.CAE was reported to manifest MI/UA during follow up  
     6.Platelet activation was well evident by high MPV ,increased 
thrombomodulin    and E selectin . 
             
            Similarly arterial vasodilators specifically calcium channel blockers 
(Diltiazem) also been suggested to counter the coronary spasm observed with 
Ectasia. But nitrate therapy is detrimental and discouraged because of its  steal 
phenomenon (further  dilatation of epicardial coronaries). The role of dua l or 
combined antiplatelet therapy have not been tried. Sorell et al proposed a 
pathophysiology combination therapy for ectasia .He recommended warfarin 
therapy to keep INR2-2.5 antiplatelet therapy with aspirin in the same dose as 
recommended  for CAD .ACE inhibitor and statin were suggested for their anti-
inflammatory effect and h s CRP reduction
72
. Trimetazidine also suggested by 
some authors 
73
 
 
Percutanoeus Coronary Intervention and Stenting : 
          Angioplasty with implantation of stenting is an option for patients with 
ectasia having symptoms despite medical therapy(refractory). Successful use 
37 
 
Balloon angioplasty in a lesion near coronary aneurysm  with excellent acute 
long term follow up have been demonstrated in 1990
74
 Appropriate  balloon, 
stent selection incomplete expansion  are the  major limitation in dealing with 
ectatic vessel. Different types of stents were used  
1. Biliary stent 
2. Autologous venous covered stent  
3. Covered stent  
4. Bare metal stent  
5. Peripheral stent  
6. Parallel stenting75 with 2 Drug elurting stent  (DES ) 
      IVUS guidance will solve the problem  inadequate expansion , poor 
apposition to wall. IVUS withdrawal should be done cautiously to avoid stent 
dislocation . Covered stents  offered superior angiographic results over BMS . 
Because of familiarity easy use and availability Suk-Kyu Oh, et al  claimed  the 
use of peripheral stent as the optimal approach . They also demonstrated the use 
of parallel ballooning using two drug eluting balloons 
76
. . In larger sized ectasia 
in angulated vessel polytertafluoroethylene (PTFE)-covered self expandable 
stent is advised 
77
. 
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Surgical Revascularisation : 
       Proximal and distal ligation surgical excision of the aneurysm segment 
followed by CABG is useful for ectasia which is not amenable to stenting . 
Irrespective of the type of procedure adopted outcome remains appreciable
78
. 
Prognosis : 
          Markis et al
7
 , after 2 yrs  follow up found annual mortality rate of  
15%/year  in CAE group which is similar to short term prognosis of patients 
with triple vessel disease received only medical therapy . On the contrary 
other landmark studies
79,19
 during initial days found no difference in  mortality 
between CAE group and isolated CAD which  disproved the hypothesis that 
“CAE confer  high risk” . In CASS registry8 also, five year survival has not 
been influenced by the presence of ectasia with that authors concluded that 
“CAE is variant of obstructive atherosclerotic disease”. 
          Recent study reported 5 yr mortality rate of 29.1% , among 276 
patients with ectasia . A Japanese study also showed poor outcome with 37% 
of  patients suffered 22 major cardiac events with 78% of the major event 
being MI or UA. Isolated ectasia is not an innocent but exercise induced 
ischemia is well documented . In a  Turkish study among 9 patients with 
isolated ectasia 46% 
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 patients with dilated coronaropathy had  dynamic ECG changes with enzyme 
elevation indicative of ACS .  
                Myocardial performance index a measure of global LV 
function(both systolic and diastolic) shown to be abnormally higher in the 
segmental territory of ectatic vessel indicating dyssynchrony due to 
underlying chronic ischemia
80
. Similarly electrical and mechanical function 
of left atrium also abnormal in CAE
81
 as evidenced by a measurement P A-
TDI   duration  (delay between the onset of P wave to Tissue Doppler A- 
indicator of total atrial conduction and mechanical function ). The link 
between CAE and LA dysfunction  is the underlying  LV diastolic 
dysfunction due to chronic ischemia which have been  demonstrated by the 
good correlation between P A TDI  and isovolumic relaxation time  , LA size 
. P A TDI identified as predictor of atrial fibrillation suggesting the 
possibility of increased incidence of AF in CAE but not yet studied .. 
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                  AIMS   AND   OBJECTIVES  
 
 
1. To assess the prevalence of Coronary Artery Ectasia in patients  with 
CAD  
2. To Analysis of Risk factors and  clinical presentation  of CAE and  
               to compare it with patients having only obstructive CAD 
 
3. To Describe the angiographic characteristics of CAE 
 
4.  To study the influence of CAE on outcome of CAD  
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      MATERIALS  AND  METHODS 
 
STUDY  POPULATION:  
      Adult patients >18 yrs. of age with the diagnosis of CAD , undergoing 
Angiography in Department of Cardiology   Govt Rajaji Hospital  
CASES: 
Inclusion criteria: 
1. Age ≥18 years  with diagnosis of CAD ( both Stable Ischemic Heart 
disease and Acute Coronary Syndrome) 
2. Patients having Coronary artery Ectasia and/or Coronary artery aneurysm      
 in  Coronary angiography  
Exclusion criteria: 
1) Age <18yrs 
2) Patients already undergone PTCA ,CABG  
3) Preexisting valvular heart disease  
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4) Preexisting cardiomyopathies  
5) Preexisting Arrhythmias  
7) Concomitant acute or chronic kidney disease  
8) Vasculitis (Kawasaki disease ,Takayasu arteritis) 
Methods  
      From the study population  after obtaining informed written consent 
detailed history were taken Demographic and personal and health information  
were collected from the patient . Blood samples were collected for laboratory 
investigations . 
LABORATORY INVESTIGATIONS: 
1) Fasting Blood Sugar  
2) Post prandial blood sugar  
3) Serum creatinine 
4) Blood urea 
5) Lipid profile  
6) HIV ELISA  
7) Echocardiography  
8) Coronary angiography  
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Definition of risk factors. 
          Diabetes Mellitus :  
               Diabetes Mellitus was diagnosed  
      1.   If a patient is already on oral hypoglycemic drugs or on Insulin therapy  
      2.    If a patient  has symptoms of  DM  
                          Plus 
               Random Blood sugar of > 200 mg/dl   or  
              Fasting blood sugar >126mg %  
       Systemic Hypertension  :    
              A patient was diagnosed to have hypertension  
        1.If he is on antihypertensive therapy  
        2. If his BP is >140/90 mm of Hg on presentation and on repeat recording       
              (>2 occasions)  
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 Lipid abnormality :  If a patient has  
1. Elevated LDL cholesterol >100 mg%       
2. High    TGL >150 mg% 
3. HDL cholesterol < 35 mg /dl                                                                               
      Any patient with  Body Mass Index > 30 kg/m
2 
 was labelled as obese 
        Definition of Acute Coronary Syndrome :         
Myocardial infarction was defined as per Universal definition of MI 
82
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Diagnosis of Unstable angina was made if  a patient fulfil any of the following 
criteria 
83
 
 
 
Coronary Angiography :  
     After obtaining an informed  written  Coronary angiography was done 
through either right femoral artery or right radial artery approach after sterile 
aseptic precaution under local anaesthesia using  Judkins right  and left (JR ,JL ) 
coronary catheter . 4 or 5 views for LAD and 2 views for RCA were recorded .  
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The films were reviewed by junior resident and findings were confirmed by 
experienced interventional cardiologist  
Angiographic views : for Left Anterior Descending Artery   
1. RAO caudal  
2. AP caudal  
3. AP cranial  
4. LAO caudal   
5. LAO cranial 
For Right Coronary Artery : 
1. LAO  
2. AP cranial  
All the 3 major vessels were  divided into  proximal,  middle, and distal 
segment as follows  
LAD :   
  Proximal LAD : From its origin from LMCA to the  origin of 1
st
 Diagonal  
  Mid LAD         : Defined as LAD segment in between 1
st
  and 2
nd
  diagonal   
   Distal LAD     :   LAD distal to 2
nd
 diagonal labelled as distal LAD  
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RCA :  
   Proximal RCA : From its ostium to the  origin of 1
st
 RV branch  
  Mid RCA         : Defined as RCA segment in between 1
st
  RV branch and its        
                             bifurcation PDA and PLV vessel   
  Distal RCA    :   RCA distal to its bifurcation as PDA and PLV vessel   
 
 LCX : 
  Proximal LCX : From its origin to the  origin of 1
st
 Obtuse marginal branch                    
 Mid  LCX     : LCX segment in between 1
st
  and 2
nd
  Obtuse marginal branch                   
Distal LCX   :  LCX distal to 2
nd
 Obtuse marginal branch  labelled as distalLCX  
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Definition of Ectasia :  
       In our study we followed the definition used in CASS registry abnormal 
dilatation of coronary artery, with luminal diameter exceeding 1.5 times the 
adjacent  normal reference segment. If no adjacent normal segment could be 
LAD  left anterior descending coronary artery;    LCX  left circumflex coronary artery; 
 LM  left main coronary artery;                                RCA  right coronary  
D1   first diagonal branch;                                           D2   second diagonal branch;   
OM  obtuse marginal branch                                    PD  posterior descending branch;  
PL  posterolateral branch                                         RPD  right posterior descending branch   
      Coutersy  Ref        
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identified, the mean diameters of the coronary segments in a control group 
without heart disease served as normal values.”   
Types of Ectasia : 
1. Localized : If ectasia confined to a discrete portion of artery with an 
adjacent normal vessel within that segment  
2. Diffuse:   if the Ectasia involves the entire coronary aretery  segment with 
no normal vessel in that segment   
                Coronary Ectasia have been classified according to Markis et al & 
Harikrishnan et al  classification  
Definition of obstructive CAD in angiogram  :  
             Obstructive CAD was diagnosed if a patient had > 50% loss of  
luminal diameter compared to the reference normal segment.  
Definition of Groups: 
       Different types of ectasia in relation the segment of particular vesselsas 
defined above were recorded . According to the angiography patients were 
categorized into three groups Group A = Isolated Ectasia patients having 
Ectasia without any evidence of significant obstruction in coronary artery 
(>50%) , Group B Mixed CAE + CAD  group Patients with Ectasia and also 
having  significant obstruction in  any of the coronaries .Group C= Pure CAD 
group patients having  only CAD without evidence of CAE  
50 
 
          Patients were treated according to the guideline given by American 
College of Cardiology /American Heart association . Left ventricular systolic 
function was recoded with Philips IE 33 echocardiography machine . Clinical 
events LVF ,in hospital mortality were recorded . Outcome data during 
follow up were collected specifically regarding the Unstable angina ,MI  
mortality and recoded for analysis 
 
Stastical Analysis  ;  
           Continuous variables were analyzed with Mean ± SD (BMI, Lipid 
parameters ,age) . Categorical variables sex ,DM hypertension ,vessel 
involved  outcome ) were described with number &  percentage .Chi Square 
test used to assess the significance  P value < 0.05 were considered as 
stastically significant. . 
   
 
 
 
                                  
 
51 
 
                                        RESULTS  
 
Prevalence : 
        Totally  2434 patients undergone  angiogram during the study period 
with the suspicion of Coronary Artery Disease (Chronic Stable Angina or Prior 
MI, ACS ).Of those 1966 patients was eligible for our study . Coronary ectasia 
was found in 136 (5.6%) patients of whom 24 (1.0%) patients were diagnosed to 
have isolated ectasia (isolated ectasia group) without evidence obstructive 
coronary disease and  112 (4.6%) (CAE+CAD group) patients with ectasia were 
having associated with obstructive CAD . Remaining1830 patients were having 
pure obstructive CAD  (CAD group)(75.2%).Baseline characters have been 
tabulated in Table 1. Isolated ectasia (dilated coronaropathy) was observed in 
17.6%(n=24 ) ,remaining 82.4%  had associated obstructive CAD  (n=112) . 
 Age & Sex : 
                Mean age of the population in isolated ectasia is significantly  lower 
(44±8.6 Vs 54.32±8.72 Vs 56±7.8  P<0.001) compared to mixed CAE +CAD 
group  and isolated CAD . Sex distribution showed male predominance in all the 
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groups .the proportion among total ectatic population is M:F 3.1:1.Significant 
male dominance was noted in Isolated ectasia group (7:1 p value <0.001). But 
when comparing total ectasia group (n=136)  to isolated CAD the male 
dominance nullified indicated that male sex is a significant risk factor for 
Dilated coronaropathy(Isolated ectasia). But male sex is not a significant risk 
factor  mixed  ectasia group (CAE+CAD)  when comparing with isolated CAD 
group the male(2.7:1 Vs 2.5:1 P value NS) dominance is due to high incidence 
of CAD among males . 
Smoking :  
         Among the isolated ectasia group 62.5% (n=15) patients were smokers 
whereas in mixed and isolated CAD group smokers were 53.6% (n=60),51.6% 
(n=944/1830) respectively. 
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   Fig  :1a
 
 
Isolataed Ectasia         CAE +CAD  
 
 
 
 
 
 
 
n=1966 
n=2434 
n=1830 
n=136 
(5.6%) 
n=24 
(1.0%) 
n=112 (4.6%) 
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Table 1: Baseline Characters 
CAD  
n= 1830  
Isolated 
Ectasia 
n=24 (1.0%) 
CAE+CAD 
(n=112)4..6% 
Study poulation & Prevalence  
 Isolated 
Ectasia n=24 
(A) 
CAE+CAD 
n=112  (B) 
CAD n=1830 
(C) 
 p value  
Age   (yrs) 44±8.6 54.32±8.72  56±7.8 <0.001  
Sex  Male   21  (87.5%) 82(73.2%)  1318(72%)   
      Female     3(12.5%) 30(26.8%) 512(28%)   
Smoker  15(62.5%) 60(53.6%) 944 (51.6%) 0.813 NS   
Diabetes 6(25%) 48(42.9%)  868(47.4%) <0.05  
SHT 8(33.3%) 53(47.3%) 904(49.4%) 0.55 NS   
BMI 
 (>30 mg /dl) 5(20.8%) 26(23.2%) 413(22.6%) NS   
LDL  
(>100 mg/dl) 7(29.2%) 41(36.6%) 679(37.1%) NS  
HDL( <35mg/dl) 13(54.1%) 51(45.5%) 866(47.3%) NS   
TGL (>150mg/dl) 5(20.8%) 43(38.3%) 763(41.7%) NS   
     
Fig 1b  :  Prevalence  
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Table : 2 Gender distribution  
 
 
 
 
 
 
 
 
Fig 2 a Gender Distribution  
 
0
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CAE+CAD
(n=112)
CAD (n=1830)
87.5 
73.2 72 
12.5 
26.8 28 
GENDER  DISTRIBUTION 
Male Female
 
Total Male n (%) Female n (%) M:F 
All patients  1966 1421(72.3%) 545(27.7%) 2.6 
Isolated Ecatsia 24 21 (87.5%) 3(12.5%) 7 
CAE+CAD 112 82(73.2%) 30 (26.8%) 2.7 
Total No CAE  
patients  136  103 (75.7%) 33(24.3%) 
3.1 
 Isolated CAD  1830 1318 (72%) 512 (28%) 2.52 
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TABLE 3 Traditional  Risk factors 
 Isolated 
Ectasia n=24 
CAE+CAD 
n=112 
CAD n=1830  p value  
Age   (yrs) 44±8.6 54.32±8.72  56±7.8 
<0.001 
Sex  Male   21  (87.5%) 82(73.2%)  1318(72%) 
 
      Female     3(12.5%) 30(26.8%) 512(28%) 
 
Smoker  15(62.5%) 60(53.6%) 944 (51.6%) 
0.813 NS 
Diabetes 6(25%) 48(42.9%)  868(47.4%) 
<0.05 
SHT 8(33.3%) 53(47.3%) 904(49.4%) 
0.55 NS 
BMI (>30 ) 25.57±3.41 27.43 ± 3.19 28.15±3.56 <0.001  
LDL  
(>100 mg/dl) 105± 22.68 104.9±19.8 108±16.7 0.12 NS   
HDL( 
<35mg/dl) 37.9±-8 36.19±7.13 37.52±6.9 0.136 NS   
TGL 
(>150mg/dl) 155.9±31.9 167.17±42.99 163.34±37.15 0.35 NS   
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Conventional Risk Factors : 
 
                 Diabetes Mellitus was observed in 25% ( n=6/24)of patients with 
isolated ectasia In mixed group  DM was seen in 48/112 patients   and in pure 
CAD 47.4% of  patients were having DM . Prevalence DM is similar in mixed  
group and pure CAD  But in isolated ectasia  prevalence of significantly lower 
44.± 8.6 
54.32±8.7 56.±7.8 
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Fig  2bAGE DISTRIBUTION  Mean± SD   
Isolated Ectasia (n=24) CAE+CAD (n=112) CAD (n=1830)
58 
 
when compared to other groups indicating the inverse association between 
Diabetes melltus & isolated ectasia not in mixed group  
                          Systemic Hypertension  was found in 33.3%  (n=8/24)of 
isolated ectasiagroup whereas in mixed and pure CAD group it was 47.3 % 
(n=53/112) and 49.4% respectively . Five among 24  isolated ectasia patients 
(20.8%)were obese with the BMI of >30 in mixed group  23.2% were obese  in 
pure CAD 22.6% were obese   .Mean   LDL  was  105± 22.68 mg% in isolated 
ectasia patients with  LDL > 100 mg % was observed in 29.2% of te patients .
  In mixed and pure CAD group mean  LDL cholesterol  was 
104.9±19.8, 108±16.7 mg% respectively with high LDL was noted among  
36.6% ,and 37.1% of the patients in these group  the difference was not 
significant .Similarly HDL cholesterol was low in half the isolated ectasia group  
54.1% but the difference between the groups were not statistically significant , 
the mean among different group was  37.9±-8 in isolated ectasia patients 
36.19±7.13 & 37.52±6.9 in mixed group and pure CAD population. 
Significantly less number of people in isolated ectasia were having 
hypertriglyceridemia but the mean level was not statistically significant across 
the 3 groups . 
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Fig : 3 Traditional RiskFactors  
 
Fig 4  Tarditional Risk factors 
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Table 4 : Novel Risk Markers   
 
Novel Risk Markers :  
 
          With the hypothesis that  inflammation  with underlying atherosclerosis is 
possible  pathogenitic mechanism of coronary artery ectasia we evaluated 
various risk markers of underlying inflammation . Mean Neutrophil count was 
significantly among isolated ectasia group and in CAE+CAD group compared to 
pure CAD group 5.986±1.497  Vs 6.019±1030 Vs 4.480±1.230 (P Value 
<0.001).In addition neutrophil to lymphocyte ratio also significantly higher (P 
Value<0.001) in Isolated and mixed ectasia group  3.98±0.89 & 3.58±0.56 when 
compared to pure CAD group 2.82±0.60. Role of Plateletlet activation was 
 Isolated Ectasia  
Mean±SD 
CAE+CAD 
Mean±SD 
Pure CAD 
Mean±SD 
p value 
Neutrophil  
(cells /mm
3
) 5.986±1.497 6.019±1030 4.480±1.230  <0.001  
Lymphocyte  1.520±0.268 1.700±0.275 1.680±0.268 0.011  
NLR  3.98±0.89 3.58±0.56 2.82±0.60 <0.001  
Mean Platelet voume 
(MPV) 9.94±1.56 9.56±1.06 9.70±1.36 
0.379 
NS   
Red Cell Distribution 
Width (RDW)  12.59±0.60 12.09±0.85 12.12±0.70 <0.005  
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assessed by measuring MPV .difference between the mean of MPV was not 
significant among the three groups   9.94±1.56  Vs  9.56±1.06 Vs 9.70±1.36 
(P=0.379). Similarly Red cell Distribution Width also measured to assess the 
inflammatory component . RDW in patients with isolated ectasia is significantly 
elevated when compared with the other groups  12.59±0.60  Vs 12.09±0.85  Vs 
12.12±0.70  P<0.005.This indicate platelet activity is not different among the 
group  indicate platelet are as active as   in isolated ectasia group but here we did 
not compare with the control group so we cannot underestimate the role of 
MPV. 
 
 
Table 4 : Angiographic Pattern  Markis classification  
 
 
 
 
 
 
 
 
 
 
Markis  
Type  
Isolated Ectasia 
N=24 (100%) 
CAE +CAD 
n=112(100%) 
Total 
N= 136 
I 
10 (41.7%) 2(1.79%) 12 (8.8%) 
II 
6(25%) 38(33.93%)  44 (32.4%) 
III 
 4(16.7%) 26(23.21%) 30 (22.0%) 
IV 
4(16.7%) 46 (41.07%) 50 (36.8%) 
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Fig  :5 a  Markis Types    in  Isolated Ectasia  
 
 
Fig  :5 b  Markis Classification in  Mixed CAE + CAD group  
 
 
10(41.7%) 
6 (25%) 
4(16.7%) 
4 (16.7%) 
Isolated Ectasia N=24 (100%) 
Type I
Type II
Type III
Type IV
2(1.79%) 
38(33.93%) 
26 (23.21%) 
46 (41.7%) 
CAE +CAD n=112(100%) 
Type I
Type II
Type III
Type IV
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Fig 6 : Markis types in Isolated Ectasia & Mixed group  
 
  Angiographic pattern :  
           Markis type IV(Isolated focal ectasia ) is the most common among both 
isolated and mixed ectasia group observed in 50 of 136 patients  (36.8%) 
followed by Type II (combined diffuse and focal ectasia ) in 44patients (32.4%) 
then Type III in 30patients (22%) finally least common is type I (Diffuse ectasia 
of 2 or more vessel) 12 (8.8%). Among the isolated ectasia group  tyepe I is the 
most common type n=10 41.7% followed by Type II n=6(25%)type III , IV 4  
16.7%each with responsible for the remaining .In this dilated coronaropathy 
group diffuse ectasia is more common than focal ectasia36 (70.6%) vs 
15(29.4%)   RCA  is the the most common vessel involved . Whereas mixed 
group had more number of focal ectasia than mixed 109 (61.2 %) vs  69(38.8%)          
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
Isolated Ectasia N=24
(100%)
CAE +CAD
n=112(100%)
Type I Type II Type III Type IV
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                  In the mixed group LAD the commonest vessel involved . When 
combining both group isolated ectasia (n=51) and mixed CAE + CAD (n=178) 
totally 229 ectasia were observed among 136 patients .RCA and LAD had equal 
number of ectasia (n=90 , 39.3%) followed by LCX (n= 40,17.5%)and then 
LMCA  n=9(3.9%). Among the vessels LAD has dominant focal involvement  
n=71 (78.9%) but all the other major vessels had dominant diffuse involvement 
RCA (58.9%)  LCX (65%) LMCA (77.8%). Totally 105 diffuse ectasia were 
identified  majority n=53 (50.5%) seen in RAC followed by  LCX, LAD  
,LMCA respectively  26 (24.8%) 19 (18.1%)  7 (6.7%) .In focal ectasia 
(n=124)group LAD contributed to the maximum number n= 71(57.2%) followed 
by RCA , LCX , LMCA ( 37 (29.8%),  14 (11.3%), 2  (1.6%)) in the descending 
order of frequency  . 
 
Table5: Total number of Ectasia in  relation with vessel 
 Isolated     ectasia   
(n=51) (100%) 
Mixed CAE+ CAD  
(n=178) (100%) 
Total  
N=229 
LMCA (n=9) 2(3.9%) 
 
7 (3.9%) 
 
9  (3.9%) 
LAD (n=90) 15(29.4%) 
 
75 (42.13%) 
 
90 (39.3%) 
LCX (n=40) 13(25.5%) 
 
27 (15.17%) 
 
40 (17.5%) 
RCA  (n=90) 21(41.2%) 
 
69(38.76) 
 
90(39.3%) 
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  Fig 7:  Vessel involvement  
 
 
 
Table 6 : Vessel Involvement in Isolated Ectasia  
 
 
 
 
 
 
0
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60
70
80
LMCA
(n=9)
LAD
(n=90)
LCX
(n=40)
RCA
(n=90)
Isolated     ectasia  n=51
Mixed CAE+ CAD  n=178
Vessel  Diffuse n=36 
(100%) 
Focal (n=15) 
(100%) 
Total (n=51) 
(100%) 
LMCA (n=2) 2 (5.6%) 0 2 (3.9%) 
LAD (n=15) 7(19.4%) 8 (53.3%) 15 (29.4%) 
LCX (n=13) 10(27.8%) 3 (20%) 13 (25.5%) 
RCA  (n=21) 17(47.2%) 4(26.7%) 21 (41.2%) 
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Table  7: Vessel Involvement in (CAE +CAD )  
 
 
 
 
 
 
 
 
 
 
Table 8 Type of Ectasia  relation with vessel  
 
 
 
 
 
 
 
 
 
 
 
 Diffuse n=69 
(100%) 
Focal (n=109) 
(100%) 
Total 
(n=178) 
(100%) 
LMCA n=7 5(7.3%) 2 (1.8%) 7 (3.9%) 
LAD n=75 12 (17.3%) 63 (57.8%) 75 (42.13%) 
LCX n=27 16 (23.2%) 11 (10.1%) 27 (15.17%) 
RCA n=69 36(52.2%) 33 (30.3% 69 (38.76) 
 Diffuse n=  105 Focal 
(n=124) 
 
Total n=229 
LMCA n=9( %) 7 (77.8%) 2  (22.2%) 9 
LAD n=90 (%) 19 (21.1%) 71(78.9%) 90 
LCX n=40( % ) 26 (65%)  14(35%)  40 
RCA n=90( %) 53 (58.9%) 37 (41.1%) 90 
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Table : 9 Distribution of ectasia in vessel 
 
  
 
 
 
 
Fig 8: Type of Ectasia  relation with vessel 
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 Diffuse n=  105  
(%) 
Focal (n=124) 
(%) 
Total n=229    
(%) 
LMCA n=9 7 (6.7%) 2   (1.6%) 9 
LAD n=90  19 (18.1%) 71(57.2%) 90 
LCX n=40 26 (24.8%) 14 (11.3%) 40 
RCA n=90 53 (50.5%) 37 (29.8%) 90 
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Table 10: Clinical Presentation  
 
Clinical 
Presentation  
Isolated 
Ectasia 
n=24 (%) 
CAE+CAD 
n=112 (%) 
CAD 
n=1830 
 (%) 
P value  
 
CSA  6(25%) 43(39.3) 768(42%) 0.46 NS 
 
UA /NSTEMI  14(58.3%) 21(18.8% 311(17%) <0.001 
 
STEMI  4(16.7%) 48(42.8%) 751(41%) <0.005  
    
 
   
Table 11 : Outcome  
  
 
 
    
 
  Isolated 
Ectasia n=24 
CAE+CAD 
n=112 
CAD n=1830  p value  
EF  59.6±4.6 53.4±9.6   51 ±6.4 <0.01  
In Hospital 
Mortality  0 7(6.3%) 104 (5.7%) 0.49  NS   
PCI  0       8    462  26.7%  
CABG  3 12.5%      46 (41.7%)    302  (17.4%)  
       
                                                        Follow up  
     
  
 
Isolated 
Ectasia  n=24 
CAE +CAD 
n=103 CAD  n=1625  P value  
Duration  12 ±2months  13±4 months  15±3 months  NA  
UA/NSTEMI 9(37.5%) 32 (31.2) 278(17.1) <0.003  
STEMI 0 5 (4.9%) 83(5.1%) <0.05  
Mortality  0 6 (5.8%) 99 6.1%) <0.05  
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Clinical Presentation  :  
      In the isolated ectasia group 58.3%  (n=14 )  P<0.001of the patients 
presented with Unstable angina /NSTEMI. CSA is the next common responsible 
for 25% (n=6)STEMI is the least common presentation  4(16.7%).On the 
contrary in mixed (CAE +CAD group and in the pure CAD group UA/NSTMI  
the least common presentation 18.8 %and 17% . But CSA is the most common 
indication for CAG in CAD group .In the mixed group STEMI (42.8%) the 
commonest presentation but the difference is not statistically significant .   
Outcome    : 
      Follow up data available foo al 24 isolated ectasia patients and for 103 
patients in mixed group 1625 pure  CAD patients .Duringfollow up UA angina is 
most frequently seen among Isolated ectasia and mixed group compared to pure 
CAD, 9(37.5%) vs vs 32 (31.2) vs 278(17.1). No ne of the isolated ectasaia 
patient had STEMI or mortality during follow up .But in mixed group 
approximately   similar  incidence of  STEMI  in mixed 5 (4.9%) and pure CAD 
group 83(5.1%).Morality during follow up also same in both mixed and pure 
CAD 6 (5.8%) and 99 (6.1%) vs 0 in isolated ectasia group  
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                                                    DISCUSSION  
           In our study conducted in South India ,totally 136 among 2434 patients 
with clinical suspicion  CAD  had coronary ectasia .So the prevalence of ectasia 
was 5.6%  Prevalence of isolated ectasia was 1% (n=24) . In the literature 
prevalence of ectasia varies from 0.3% - 12.5%. the highest prevalence reported 
in Indian subcontinent (India -10-12%, Pakistan 12.5%) . Except few studies 
majority   reported  prevalence  < 5% ( CASS registry- 4.9% Spain- 3.39% , 
Greek 2.7% ) Similarly  Harikrishnan et al from Kerala –South India reported 
4.5% among 3200 angiogram   The prevalence isolated ectasia without 
significant coronary stenosis (dilated coronaropathy)  in our study was 1%(n=24 
) . Harikrishnan et al reported prevalence of 0.6 %  Nyamu et al in their 
dedicated study on isolated ectasia reported a prevalence of 1.9% among 6938 
angiogram . 
Association with CAD : 
     Isolated ectasia (dilated coronaropathy) was observed in 17.6%(n=24 ) of all 
ectasia   remaining  82.4%  had associated obstructive CAD  (n=112) .  Pinar 
Bermúdez  et al in their study found that 77.6% of the CAE patients had 
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associated stenosis   CSP Lam et al from Singapore observed 82% of their 
patients with CAE had associated  obstructive CAD  . Several studies reported  
similar observation and  P. Ramappa, et al  in their excellent  review reported  
found >50% of patients with ectasia  in the literature had underlying  stenotic 
atherosclerosis . In view of  its significant association with atherosclerosis CASS 
registry concluded Coronary Ectasia as a variant of atherosclerosis . But further 
studies following CASS registry done to explore the relation between the 
traditional risk factors of found contradictory results.  
Isolated ectasia - Is it a right terminology ??? 
       By definition isolated ectasia excludes atherosclerosis, connective tissue  
valvular  and congenital disease . But Ge et al in a IVUS based study found that 
atheroma burden even inside the ectatic segment . Similarly in our angiographic 
study 40 % of patients with isolated ectasia had non-significant stenosis with  
30-40%narrowing of lumen . Conventional coronary angiogram is less sensitive 
in detecting narrowing less than 30% with ectasia luminal loss may also  be 
underestimated .Hence it does not recognize minimal atherosclerosis, require 
IVUS to pick up this  minimal atheroma So the terminology of isolated ectasia 
itself was questioned by “Boles U” who recommended ectasia with non-
obstructive CAD for isolated ectasia   . 
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Traditional Risk factors & CAE :   
     Patients in the isolated ectasia group were   younger than other groups 
(44±8.6 Vs 54.32±8.72 Vs 56±7.8  P<0.001) .This finding is consistent with the 
finding of some   previous studies .Gender distribution   showed male 
predominance in all the groups .the proportion among total ectatic population is 
M:F 3.1:1.Significant male dominance was noted in Isolated ectasia group (7:1 p 
value <0.001). But when comparing total ectasia group (n=136)  to pure CAD 
the male dominance nullified indicated that male sex is a significant risk factor 
for Dilated coronaropathy(Isolated ectasia). But male sex is not a significant risk 
factor  mixed  ectasia group (CAE+CAD)  when comparing with isolated CAD 
group the male(2.7:1 Vs 2.5:1 P value NS) dominance is due to high incidence 
of CAD among males . Male dominance(M:F 2-3:1) was noted in some previous 
studies also especially in isolated ectasia group but no statistical significance 
was found between   CAD and CAE group
85
 .Some authors attributed that the 
difference is due to lower incidence of CAD among women  but G G Hartnell 
reported significant male dominance  despite the allowance given for lower 
incidence of CAD in females  .   
        Of the traditional risk factors Diabetes mellitus has unique position with 
ectasia  Giannoglou GD et al   Williams SB   et al  reported negative association 
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between ectasia and diabetes mellitus  . After a metaanalysis Huang et al  
concluded that DM has inverse association with CAE  and act as a protective for 
too. In our study we found  a similar relation between ectasia and DM  6 (25%) 
vs 48(42.9%) vs 868(47.4%) <0.05 with significantly lower incidence of DM in 
isolated ectasia group comparted mixed and pure CAD group. But there was no 
difference between mixed and pure CAD group  which suggestive of significant 
inverse relation between DM and  isolated ectasia .  Other traditional risk factors 
like LDL HDL does not different among all the three groups . .But people with 
isolated ectasia had significantly lower BMI compared to others .Which we 
suspected probably due to less incidence of Diabetes in ectasia group .  
Novel Risk markers : 
      Evidence for the relation between inflammation and CAE  becoming 
strong day by day .In line with these observation  our study also showed high 
neutrophil count and NLR in CAE group  compared to pure CAD group. Mean 
Neutrophil in CAE vs mixed CAE +CAD vs pure CAD is 5.986±1.497  Vs 
6.019±1030 Vs 4.480±1.230 (P Value <0.001) NLR is 3.98±0.89 & 3.58±0.56 
vs 2.82±0.60. . Elevated markers of neutrophil mediated inflammation have 
already been demonstrated in  by CAE Turhan H etal , and Li JJ et al86. This 
high inflammatory activity have been proposed as the explanation for  CAE in 
some CAD in others . MPV platelet volume a marker of hyperactive platelet 
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found to be higher among CAE compared to healthy control but similar between 
CAE and CAD group .This was indirectly supporting the hypothesis that CAE & 
CAD formed from same pathogenitic mechanism .Here in our study MPV was 
not significantly different between groups.  But we did not compare with the 
control Another indirect  marker of inflammation is  RDW which was 
significantly elevated among isolated CAE compared to CAD  similar to report 
by Xiao-Lin Li et al . Hence our study also supporting the inflammatory 
hypothesis. 
Angiographic pattern  :  
          Markis type IV(Isolated focal ectasia ) is the most common among both 
isolated and mixed ectasia group observed in 50 of 136 patients  (36.8%) 
followed by Type II (combined diffuse and focal ectasia ) in 44patients (32.4%) 
then Type III in 30patients (22%) finally least common is type I Diffuse ectasia 
d .In the mixed group LAD the commonest vessel involved . When combining 
both group isolated ectasia (n=51) and mixed CAE + CAD (n=178) totally 229 
ectasia were observed among 136 patients .RCA and LAD had equal number of 
ectasia (n=90 , 39.3%) followed by LCX (n= 40,17.5%)and then LMCA  
n=9(3.9%). Among the vessels LAD has dominant focal involvement  n=71 
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(78.9%) but all the other major vessels had dominant diffuse involvement RCA 
(58.9%)  LCX (65%) LMCA (77.8%). . 
Clinical Presentation:   
         Type of clinical presentation is significnly different in isolated ectasia 
group compared to others .In this group Unstable angina /NSTEMI  most 
common presentation .STEMI is the least common form of presentation .Only 4 
(16.7%) patients with isolated ectasia  compared to  other groups  (42.8% ,41% ) 
it was significantly low . Similar to our study Y Guines also reported 17% of MI 
among ectasia group but the clinical presentation was not stastically significant 
in their groups . Similar to  a study  from Iraq  25 % of our isolated ectasia 
patients had CSA .  
Follow up :   
    Outcome of isolated ectasia in our group is entirely different from other 
group .In mixed and pure CAD group except for unstable angina during follow 
up 32 (31.2) 278(17.1) which high in CAE + CAD group , other events were 
similar including  , mortality during hospital stay and  follow up This suggests 
similar character of CAE associated with CAD and  indicate that CAE does not 
increase the mortality in CAD patients but produce recurrence of symptoms 
despite medical therapy .But in the isolated ectasia group ,no mortality at all  
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during hospital stay and follow up .But recurrence of angina is high which is 
similar to mixed group and indicate that presence of ectasia increase the 
recurrence of angina . 
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                       SUMMARY and HYPOTHESIS 
 
1. Association of CAE with obstructive CAD (82.4%) and similar  risk 
profile even DM in both mixed CAE+ CAD and pure CAD group,  
supports the hypothesis  that underlying pathogenesis in CAE  CAD are  
same which is atherosclerosis. 
 
2. Even though   non-significant   but  presence of 30-40% narrowing even 
in isolated ectasia favors  atheroma as the basis even for CAE  .By the 
way this new finding questions  the terminology of isolated ectasia and we 
support the terminology “ectasia  non-obstructive CAD”  recommended 
by   “Boles U”  for isolated ectasia  
 
3. But why some people develop CAE others not? The answer for the 
question comes from the  lesser incidence of DM (negative association) in 
isolated ectasia group  and inflammatory markers  essential finding in our  
study . 
 
4. Absence of Diabetes with increased inflammation favors  the ectasia 
formation . Presence DM enhances process of atherosclerosis and direct it 
80 
 
towards negative remodeling rather than  ectasia (positive remodeling) 
This i negative remodeling effect of DM mediated by Advanced glycation 
End products  which inhibit the effect of MMP and increase the stiff ness 
of vessel  
 
5. Patients with isolated ectasia are more younger relative to the other 2 
groups  
 
6. Atherosclerosis is a slowly progressing disease with extremes effect on 
vascular tree.  On one side aneurysm formation (dilatation) , other side 
with obstructive (narrowing)  
 
7. By recapitulating Glagovian  phenomenon  and with current knowledge 
and evidence from our study  ,we agree with E. Yetkin and J. 
Waltenberger and extending their concept to formulate this  
hypothesis that “ectasia may be an early stage expression of 
atherosclerosis  when neutrophil mediated  inflammatory phenomenon  
dominates  .Obstructive disease is an expression of late stage  wherein the  
mechanism is different and  CAE + CAD is an intermediate transitory 
stage ”  and this need larger properly planned study for  comprehensive 
evaluation(including vascular morphology assessment with HPE )  
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8. Another finding from our study is MPV is elevated but  did not differ 
significantly between groups  So platelet is active  in all the stages   which 
necessitates the antiplatelet therapy through entire spectrum of 
atherosclerosis  
 
9. Here we are not able to explain the role of dyslipidemia  
10. Clinical expression of  mixed group is not much different from  pure 
CAD. And it does not worsen the prognosis further more than CAD  
except  for increased frequency of anginal episode . 
11.  But  isolated ectasia group have 0% mortality with significantly better 
systolic function EF .But even here to the  frequency angina is higher . 
This indicate Ectasia has the propensity to increase angina but does not 
affect the mortality . 
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                       CONCLUSION  
 
          Isolated ectasia is a  unique phenomenon ,  seen in relatively younger 
population , having  inverse  association (less frequent) with  Diabetes mellitus , 
neutrophil mediated active inflammation  and this has nil  effect on mortality . 
But Coronary artery  ectasia if associated  obstructive CAD  has evidence of 
high inflammatory activity than pure CAD ,but  does not worsen the prognosis 
of coexisting CAD except for increased frequency of  unstable angina . 
 
 
 
LIMITATIONS 
1. The number of population in isolated group is very less  
2. Other inflammatory markers hs CRP  were not assessed  
3. Healthy controls were not selected for comparison  . 
4. Diastolic function was not assessed 
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ABBREVIATIONS 
ACS  - Acute Coronary Syndrome 
AWMI – Anterior Wall -Myocardial Infarction 
CAD – Coronary Artery Disease 
LV – Left Ventricle 
MI   - Myocardial Infarction 
PCI – Percutaneous Coronary Intervention 
ICAM  – Inter Cellular Adhesion molecules  
VCAM – Vascular Cell Adhesion Molecule  
MPV –Mean Platelet Volume  
RDW –Red Cell Distribution Width 
NLR -Neutrophil Lymphocyte Ratio 
In Master Chart 
Y    Yes         D --  Diffuse ectasia  
F –Focal Ectasia  
1,2,3= Focal Ectasia  
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S No Ip No  Age  Sex Smoker  DM  SHT  BMI  LDL 
(mg%) 
HDL(mg%) TGL(mg%)  Neutrophil Lymphocyte NLR MPV RDW 
1 512 43 M Y N Y 25.7 120 28 165 7.14 1.54 4.64 8.9 12.34 
2 1340 42 M Y N N 22 97 34 146 5.5 1.43 3.85 11.2 12.5 
3 3345 51 M Y N N 23.4 88 53 149 6.12 1.31 4.67 7.6 12.95 
4 7834 46 M N N N 23 94 45 138 5.23 1.7 3.08 9.4 12.87 
5 9716 32 M Y Y Y 31.5 126 30 145 7.34 1.61 4.56 8.6 12.98 
6 12345 49 M Y N N 26 100 52 140 4.43 1.16 3.82 11.8 12.14 
7 16790 30 F N N N 26 90 31 178 4.24 1.2 3.53 9.2 12.97 
8 18904 57 M Y N Y 25 87 33 136 6.56 1.94 3.38 7.4 12.72 
9 23489 41 M Y Y Y 25.5 130 29 223 8.11 1.67 4.86 11.9 11.65 
10 37008 37 M Y N N 24.8 92 45 130 7.23 1.48 4.89 7.8 10.97 
11 38987 54 F N Y N 24 93 33 150 4.64 1.38 3.36 9.2 12.12 
12 42560 46 M N N N 32 118 47 148 4.42 1.17 3.78 9.9 12.47 
13 47134 42 M N N N 25.6 100 32 143 6.56 1.2 5.47 10.7 12.9 
14 50235 41 M Y N N 25 84 42 139 5.34 1.11 4.81 9.7 11.86 
15 53478 40 M Y Y Y 35 148 33 256 8.74 1.64 5.33 12.6 12.89 
16 52989 37 M N N N 21 88 44 150 4.13 1.81 2.28 10.4 12.78 
17 54760 29 F N N Y 24 96 28 147 7.65 1.72 4.45 8.9 12.92 
18 55890 40 M Y Y N 22 93 40 133 5.12 2.1 2.44 7.6 12.82 
19 57878 45 M N N Y 22 99 45 143 3.96 1.45 2.73 10.7 13.91 
20 62340 43 M N N N 30 169 34 139 3.49 1.23 2.84 11.3 11.72 
21 64768 55 M Y N N 23.8 76 45 138 7.85 1.83 4.29 12.6 12.99 
22 66540 65 M Y Y Y 26 139 31 220 7.42 1.64 4.52 9.7 12.96 
23 73467 40 M N N N 24 100 30 140 6.53 1.72 3.80 10.1 12.79 
24 77818 52 M Y N N 26.3 100 46 146 5.92 1.43 4.14 11.4 12.94 
 
  
   Angiographic pattern   ECTASIA  Clinical Presentation  OUTCOME  & Follow up  Mortality  
S No Ip No  LMCA  LAD  LCX  RCA  CSA UA  MI  EF  UA  MI  Inhosp  Follow up  
1 512 D F   F   Y   62         
2 1340   D D D   Y   58   Y     
3 3345   F D F   Y   56.8 Y       
4 7834   F   D Y     64   Y     
5 9716   D D D   Y   61         
6 12345       F Y     64         
7 16790   D D D   Y   60 Y       
8 18904   D   D   Y   62.5         
9 23489   F F       Y 49         
10 37008     D D   Y   67 Y       
11 38987     D D Y     60 Y       
12 42560 D F   F   Y   64.8         
13 47134       D   Y   55         
14 50235   D D D   Y   58         
15 53478       D     Y 50 Y Y     
16 52989   D D D   Y   57         
17 54760     D D     Y 53 Y       
18 55890         Y     62         
19 57878   F   D   Y   64.6   Y     
20 62340   F   D   Y   59.6         
21 64768   F F D Y     61 Y Y     
22 66540       D     Y 57         
23 73467   D D D Y     60 Y       
24 77818     F     Y   64 Y       
 
  
                               
S 
No 
Ip No  Age  Sex Smoker  DM  SHT  BMI  LDL 
(mg%) 
HDL(mg%) TGL(mg%)  Neutrophil Lymphocyte NLR MPV RDW 
1 105 46 F N   Y 22.4 100 38 134 4.16 1.31 3.18 9.21 12.34 
2 80346 56 M Y Y Y 31 141 29 190 4.29 1.42 3.02 8.92 10.4 
3 79980 42 M Y   Y 23.8 97 25 128 5.12 1.48 3.46 9.12 11.2 
4 1342 55 M Y     24.5 87 42 149 6.12 1.65 3.71 7.21 12.9 
5 79729 54 F N Y   21 118 31 129 5.67 1.59 3.57 10.87 11.86 
6 1388 36 M Y     26.4 99 42 136 7.91 1.7 4.65 11.92 12.87 
7 1423 65 F N Y Y 26 134 33 235 6.66 1.83 3.64 9.57 12.98 
8 1456 71 F N Y   24 99 35 254 5.8 1.49 3.89 9.89 12.14 
9 1812 62 M Y   Y 22 95 45 144 7.2 2.21 3.26 9.76 10.12 
10 2114 58 M N   Y 27 111 50 139 6.92 1.7 4.07 11.2 11.72 
11 2574 54 M Y Y   25 86 30 224 5.9 1.87 3.16 8.34 12.92 
12 3261 50 M Y     26.8 92 43 129 4.9 1.7 2.88 12.54 11.86 
13 3652 52 M Y   Y 29 116 34 137 5.8 1.74 3.33 9.87 12.79 
14 5121 30 M Y     25.6 99 45 136 4.97 1.67 2.98 8.75 11.2 
15 7002 44 F N Y Y 32.4 115 31 220 3.93 1.23 3.20 12.89 12.9 
16 8831 54 M N     24.9 87 37 145 5.61 1.41 3.98 7.89 11.86 
17 8821 51 M Y Y Y 22.8 129 42 143 5.71 1.76 3.24 9.34 12.87 
18 9306 50 M Y     29 95 29 158 3.91 1.82 2.15 10 12.94 
19 9402 65 M Y Y Y 35 139 47 138 4.31 1.43 3.01 9.97 12.14 
20 9720 62 M Y   Y 27 87 29 200 4.41 1.67 2.64 9.85 11.82 
21 10420 47 M Y Y Y 24.6 145 23 219 4.42 1.38 3.20 9.92 12.79 
22 10298 38 M Y     32.6 100 49 137 4.72 1.23 3.84 8.91 11.86 
23 11341 52 M N     27 92 44 165 5.9 1.69 3.49 10.45 12.34 
24 11560 55 F N     26 114 27 149 5.27 1.64 3.21 8.99 12.75 
25 11738 57 M Y Y Y 33.2 128 43 147 5.12 1.57 3.26 9.02 11.95 
26 12427 63 M Y     23 87 47 150 4.41 1.31 3.37 8.87 12.97 
  
   Angiographic pattern   ECTASIA  Clinical Presentation  OUTCOME  & Follow up  Mortality    
S No Ip No  LMCA  LAD  LCX  RCA  CSA UA  MI  EF  UA  MI  Inhosp  Follow 
up  
1 105       D   Y   57.5 Y       
2 80346   F D   y     60   Y     
3 79980       D   Y   58.8         
4 1342   F   D     Y 49 Y   Y   
5 79729   F   D y     62         
6 1388   D   D   Y   55   Y   Y 
7 1423   F D   Y     64         
8 1456       D     Y 48         
9 1812   2 2     Y   61 Y       
10 2114     Y   y     55         
11 2574   D         Y 46.8         
12 3261 Y         Y   54         
13 3652   D D   Y     58         
14 5121   D         Y 50 Y       
15 7002   F   D Y     56 Y       
16 8831   2 2     Y   57         
17 8821   F   D y     60         
18 9306   D D D   Y   49         
19 9402   D   F Y     60 Y       
20 9720       D   Y   56   Y     
21 10420   D F D y     65 Y       
22 10298   2 2   Y     70.2         
23 11341       D     Y 52         
24 11560   1         Y 50.4         
25 11738   F   D     Y 45     Y   
26 12427 Y         Y   56 Y       
                                
S 
No 
Ip No  Age  Sex Smoker  DM  SHT  BMI  LDL 
(mg%) 
HDL(mg%) TGL(mg%)  Neutrophil Lymphocyte NLR MPV RDW 
27 12512 74 M N     23.4 85 32 283 6.43 1.23 5.23 8.98 12.88 
28 12122 54 M Y Y   31.3 120 34 146 6.67 1.78 3.75 9.98 12.14 
29 13426 57 M Y   Y 26 131 41 143 5.71 1.8 3.17 9.96 10.36 
30 13612 52 M N     23 77 42 144 6.12 1.67 3.66 9.75 11.72 
31 13980 64 M Y Y Y 32 89 31 190 5.13 1.12 4.58 9.23 11.65 
32 14100 61 F N     28 99 39 127 5.54 1.86 2.98 10.45 10.57 
33 14212 39 M Y     29 83 28 180 3.92 1.43 2.74 9.23 11.12 
34 14676 56 M N Y Y 25.7 126 39 132 7.76 1.92 4.04 9.96 12.49 
35 13782 58 M Y     24.9 90 34 176 5.98 1.58 3.78 9.24 11.86 
36 14880 56 F N   Y 32 87 44 137 3.71 1.41 2.63 9.87 12.5 
37 15602 53 F N Y Y 28.2 120 42 189 4.84 1.17 4.14 9.91 11.95 
38 15304 57 M Y Y   24.9 96 30 320 5.62 1.21 4.64 9.72 12.87 
39 15798 51 M N Y   26.5 85 45 228 6.72 1.47 4.57 9.67 12.98 
40 15902 34 M Y     32.1 119 36 142 6.54 1.78 3.67 9.89 12.74 
41 16008 51 F N   Y 25.8 86 34 132 7.84 1.94 4.04 10.67 11.23 
42 16112 50 M Y Y Y 33.2 145 38 176 5.98 1.7 3.52 8.47 11.72 
43 16342 54 M N Y Y 25 139 26 200 6.97 1.89 3.69 9.89 11.45 
44 16443 54 M Y     34.4 97 45 145 6.23 1.45 4.30 11.23 10.97 
45 16724 68 M Y     27 89 52 134 6.75 1.89 3.57 9..56 12.32 
46 16902 63 F N Y   24.8 87 29 131 7.12 1.9 3.75 9.87 12.78 
47 17016 65 M Y   Y 26.7 99 27 265 5.67 1.45 3.91 8.78 11.92 
48 17918 64 M N Y Y 34.2 150 33 141 6.45 1.56 4.13 7.92 10.12 
49 18236 52 M Y     25.8 86 45 142 5.13 1.36 3.77 11 13.1 
50 18453 58 F N     28.4 89 49 143 6.54 1.62 4.04 9.54 11.2 
51 19230 53 F N Y Y 27 95 32 248 5.92 1.45 4.08 8.72 12.9 
52 20431 65 M N Y Y 31.8 131 36 142 5.62 1.23 4.57 7.08 11.96 
 
       Angiographic pattern   ECTASIA  Clinical Presentation  OUTCOME  & Follow up  Mortal
ity  
  
S No Ip No      LMCA  LAD  LCX  RCA  CSA UA  MI  EF  UA  MI  Inhosp  Follo
w up  
27 12512     1       y     64         
28 12122           D     Y 46.8 Y       
29 13426       D     y     61.5         
30 13612       1         Y 40         
31 13980       F   D   Y   67       Y 
32 14100       1       Y   62   Y     
33 14212       F D       Y 41 Y       
34 14676           D   Y   60         
35 13782         D       Y 59         
36 14880     1         Y   65 Y     Y 
37 15602       F   D y     61         
38 15304       D         Y 57         
39 15798         1   y     58         
40 15902           D     Y 36         
41 16008       F D       Y 41 Y       
42 16112       F   D Y     56         
43 16342       D   F y     58.2       Y 
44 16443       2 2   Y     62.4         
45 16724           D     Y 36.5         
46 16902         1       Y 45.6         
47 17016       F   D Y     65         
48 17918       F D   y     60         
49 18236       1       Y   67 Y       
50 18453           D     Y 46         
51 19230       3 3 3     Y 41         
52 20431       F   D Y     69 Y       
 
                               
S 
No 
Ip No  Age  Sex Smoker  DM  SHT  BMI  LDL 
(mg%) 
HDL(mg%) TGL(mg%)  Neutrophil Lymphocyte NLR MPV RDW 
53 20450 52 M Y     29 94 42 141 6.71 1.56 4.30 9.71 12.79 
54 22134 50 M Y     26 92 27 175 7.34 1.83 4.01 9.42 12.14 
55 22750 55 F N     28.2 117 49 139 7.23 2.11 3.43 9.12 12.64 
56 23982 60 M N Y Y 30 97 34 223 6.43 1.65 3.90 8.21 12.34 
57 24113 66 M Y     26.9 87 41 133 4.23 1.49 2.84 7.27 12.5 
58 24523 64 M Y Y   24.7 131 29 253 5.49 1.24 4.43 9.62 11.95 
59 25678 55 F N     24 99 47 146 4.89 1.56 3.13 9.57 12.87 
60 26563 53 M Y   Y 31.7 93 42 147 6.62 1.52 4.36 9.89 12.98 
61 26775 60 M Y Y Y 35 133 29 242 5.39 1.74 3.10 9.76 12.14 
62 27891 76 M N   Y 27 79 39 143 3.84 1.5 2.56 9.27 10 
63 28113 61 M Y     26.6 86 36 149 4.92 1.72 2.86 8.34 11.72 
64 28654 54 M N   Y 24.4 85 31 139 6.89 1.9 3.63 9.54 11.65 
65 29300 62 M Y Y   29.6 93 37 200 6.2 1.78 3.48 8.87 10.97 
66 29876 57 M Y Y Y 32 97 43 134 6..76 1.82 3.71 9.85 10.97 
67 30012 49 F N Y   27.2 112 27 197 5.08 1.48 3.43 9.94 12.12 
68 30129 55 M N   Y 27 92 41 138 5.3 1.7 3.12 8.19 11.74 
69 31467 43 M Y     26 119 44 137 5.92 1.89 3.13 6.34 12.9 
31 31547 42 F N     26.3 96 24 312 6.21 1.67 3.72 10 11.86 
71 32765 54 M Y Y Y 27.8 139 33 134 7.15 1.92 3.72 9.97 10.99 
72 32890 48 M N     26 93 46 142 6.63 1.86 3.56 9.85 12.68 
73 33123 66 M Y Y   33 95 29 231 6.49 1.72 3.77 9.92 11.97 
74 33567 60 F N     28.9 97 48 144 4.92 1.8 2.73 8.91 12.78 
75 34567 46 M Y Y Y 27.6 127 25 195 5.76 1.9 3.03 10.95 11.92 
76 35789 59 F N     25.7 87 44 149 6.78 1.92 3.53 8.99 10.12 
77 36142 57 M Y     25 84 28 176 5.34 1.99 2.68 9.02 13.71 
78 37456 45 M Y Y Y 26.1 87 29 226 6.23 1.78 3.50 8.87 11.72 
                                
  
        Angiographic pattern   ECTASIA  Clinical Presentation  OUTCOME  & Follow up  Mortality    
S No Ip No      LMCA  LAD  LCX  RCA  CSA UA  MI  EF  UA  MI  Inhosp  Follow 
up  
53 20450           1     Y 51         
54 22134       F   D     Y 48 Y       
55 22750       2   2   Y   57         
56 23982         D F Y     65         
57 24113       D         Y 42         
58 24523       2   2 Y     56         
59 25678       D         Y 50 Y       
60 26563         D F y     58         
61 26775       F   D   Y   65     Y   
62 27891       1         Y 47         
63 28113       D   D y     64.8 Y       
64 28654       2   2     Y 43         
65 29300         1       Y 51         
66 29876       F   D Y     60         
67 30012       F D       Y 45.8 Y       
68 30129       2   2     Y 41         
69 31467     D F   F     Y 46         
31 31547           1     Y 50         
71 32765       F D   Y     67   Y     
72 32890           D     Y 34         
73 33123       1     Y     54         
74 33567           1     Y 36         
75 34567           1   Y   67     Y   
76 35789       2   2     Y 39 Y       
77 36142           F     Y 45         
78 37456       2   2 Y     56 Y       
 
                                
S 
No 
Ip No  Age  Sex Smoker  DM  SHT  BMI  LDL 
(mg%) 
HDL(mg%) TGL(mg%)  Neutrophil Lymphocyte NLR MPV RDW 
79 37908 30 M N     27.6 83 41 129 6.79 1.56 4.35 8.98 12.91 
80 38132 48 M Y Y Y 29.6 117 43 127 7.12 1.98 3.60 9.98 11.86 
81 38654 61 F N   Y 26.2 97 27 244 6.7 1.45 4.62 9.96 12.79 
82 39160 67 M Y   Y 24.7 119 39 123 4.98 1.67 2.98 9.75 12.94 
83 39735 56 M Y     22.8 98 45 139 5.96 1.78 3.35 11.23 13.18 
84 40987 51 F N Y Y 31.4 148 27 219 6.54 1.87 3.50 10.45 11.29 
85 42342 59 M Y     23 129 41 143 6.1 1.52 4.01 9.23 12.89 
86 42998 40 M Y Y   26 98 32 182 6.46 1.72 3.76 9.96 11.96 
87 43506 64 M N   Y 30.5 89 42 147 7.89 2.1 3.76 9.24 12.49 
88 43978 45 M Y     29 145 44 136 8.46 3.2 2.64 9.87 12.94 
89 44320 53 M Y Y Y 26.8 98 34 179 6.7 1.84 3.64 9.91 12.86 
90 44765 48 F N     27.5 86 47 135 5.43 1.93 2.81 9.72 11.95 
91 45797 58 M N Y Y 24.9 112 42 145 6.12 1.54 3.97 9.67 12.87 
92 47657 55 F N   Y 32.4 74 31 183 6.79 1.79 3.79 12.69 12.98 
93 48797 68 M Y   Y 27 99 41 147 7.23 1.67 4.33 10.67 12.14 
94 49876 62 M N Y Y 26.9 120 31 149 6.13 1.78 3.44 9.97 10.98 
95 49897 53 M Y Y   25.7 115 27 220 6.84 1.45 4.72 9.89 11.72 
96 50976 44 M N   Y 24 89 45 146 7.12 1.96 3.63 11.23 13.91 
97 51113 59 F N     24.7 86 30 134 4.98 1.64 3.04 9.56 11.28 
98 53972 52 M Y Y Y 36 135 39 137 5.84 2.1 2.78 9.87 12.92 
99 54675 67 M Y Y   27 93 29 193 5.97 1.65 3.62 8.78 11.96 
100 56743 60 M N Y Y 28.2 132 37 144 6.98 1.93 3.62 7.92 12.79 
101 57567 50 F N     26.4 97 37 141 6.79 1.89 3.59 11 12.94 
102 58902 46 M N   Y 25.6 92 39 149 6.54 1.76 3.72 9.54 10.92 
103 59136 43 M Y Y   23.7 114 31 198 5.12 1.94 2.64 8.72 10.12 
104 61900 47 F N     27 97 40 142 7.34 1.89 3.88 7.08 11.14 
 
       Angiographic pattern   ECTASIA  Clinical Presentation  OUTCOME  & Follow up  Mortality    
S No Ip No      LMCA  LAD  LCX  RCA  CSA UA  MI  EF  UA  MI  Inhosp  Follow 
up  
79 37908           1     Y 52         
80 38132       F   D Y     65 Y       
81 38654       1         Y 39         
82 39160       2   2     Y 31         
83 39735       F   D Y     64 Y       
84 40987         D F Y     65         
85 42342           1   Y   56         
86 42998       2   2     Y 24     Y   
87 43506       F   D Y     54         
88 43978       2   2     Y 43 Y       
89 44320       F D   Y     60 Y       
90 44765           D     Y 36         
91 45797       2   2 y     57         
92 47657       F   D     Y 47 Y       
93 48797             Y     56         
94 49876       2   2 Y     68         
95 49897     D   F F Y     61 Y     Y 
96 50976       1         Y 45         
97 51113     D F   F   Y   58     Y   
98 53972       F D       Y 44         
99 54675           1 Y     56         
100 56743       1     Y     61 Y       
101 57567       1         Y 34         
102 58902       2   2     Y 49         
103 59136           D Y     57         
104 61900       2   2     Y 42 Y       
 
 
                               
S 
No 
Ip No  Age  Sex Smok
er  
DM  SHT  BMI  LDL 
(mg%
) 
HDL(m
g%) 
TGL(m
g%)  
Neutro
phil 
Lympho
cyte 
NLR MPV RDW 
105 62654 65 M Y Y Y 29 137 33 147 7.28 1.92 3.79 9.87 10.72 
106 65890 54 F N     31.6 99 41 137 6.99 1.86 3.76 9.91 12.91 
107 66726 59 M Y Y   22.9 160 28 213 6.89 1.94 3.55 9.82 12.86 
108 68900 52 F N Y Y 27.6 127 31 133 6.96 1.98 3.52 9.67 10.87 
109 70987 39 M Y     26.5 98 32 151 6.9 1.85 3.73 9.89 12.72 
110 72346 46 M Y     28.6 87 41 130 7.34 1.76 4.17 8.67 11.87 
111 75002 52 F N   Y 29 94 43 139 5.62 1.98 2.84 7.98 12.91 
112 79896 50 F N Y   27.8 79 33 227 7.23 2.18 3.32 8.87 11.86 
 
 
       Angiographic pattern   ECTASIA  Clinical Presentation  OUTCOME  & Follow up  Mortal
ity  
  
S No Ip No      LMCA  LAD  LCX  RCA  CSA UA  MI  EF  UA  MI  Inhosp  Follo
w up  
105 62654           1     Y 44     Y   
106 65890       1       Y   57         
107 66726       2 2   Y     62.5 Y       
108 68900       1         Y 46.4         
109 70987       2   2 Y    64 Y       
110 72346           D Y     59         
111 75002       2   2     Y 43         
112 79896       F   D   Y   57 Y     Y 
 
 
 
  
 
 
 
 
 
 
Ectasia of LMCA   +  LAD (Focal )  +  
LCX arteries  with obstructive  CAD 
  
 
 
 
 
Young female presented with 
AWMI had  
Ectasia of RCA  (8mm)  + total 
occlusion in LAD with thrombus 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Ectasia of LAD  (6.5mm )  
with stasis of dye 
  
 
 
 
 
 
 
 
 
 
 
Focal Ectasia of LAD 
  
 
Ectasia of LCX 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
A 30 years male patients presented with inferior wall 
MI   -RCA is Ectatic (6.5 mm size) having thrombus 
inside.  
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